Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Vertex Pharmaceuticals Incorporated.
Vertex Pharmaceuticals Incorporated business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Vertex Pharmaceuticals Incorporated are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Vertex Pharmaceuticals Incorporated , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Vertex Pharmaceuticals Incorporated including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Vertex Pharmaceuticals Incorporated and all latest updates of the company are provided.
The 2025 version of Vertex Pharmaceuticals Incorporated report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Vertex Pharmaceuticals Incorporated- Key Facts
2.2 Vertex Pharmaceuticals Incorporated- Geographic Locations
2.3 Vertex Pharmaceuticals Incorporated- Subsidiaries and Affiliates
2.4 Vertex Pharmaceuticals Incorporated- Business Divisions
2.5 Vertex Pharmaceuticals Incorporated- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Vertex Pharmaceuticals Incorporated Strategic Analysis Review
3.1 Vertex Pharmaceuticals Incorporated- Key Strategies
3.2 Vertex Pharmaceuticals Incorporated- Company Outlook Statement
3.3 Vertex Pharmaceuticals Incorporated- SWOT Analysis
3.3.1 Vertex Pharmaceuticals Incorporated- Key Strengths
3.3.2 Vertex Pharmaceuticals Incorporated- Key Weaknesses
3.3.3 Vertex Pharmaceuticals Incorporated- Potential Opportunities
3.3.4 Vertex Pharmaceuticals Incorporated- Potential Threats
3.4 Vertex Pharmaceuticals Incorporated- Key Competitors
4. Business Description of the Company
4.1 Vertex Pharmaceuticals Incorporated- Business Overview
4.2 Vertex Pharmaceuticals Incorporated- Operations by Segment
5 Products and Services Details
5.1 Vertex Pharmaceuticals Incorporated- Key Products
5.2 Vertex Pharmaceuticals Incorporated- Key Service Areas
5.3 Vertex Pharmaceuticals Incorporated- Key Brands
6 Company Developments
6.1 Vertex Pharmaceuticals Incorporated- Company History
6.2 Vertex Pharmaceuticals Incorporated- Latest Developments
7 Financial Analysis
7.1 Vertex Pharmaceuticals Incorporated- Income Statements
7.2 Vertex Pharmaceuticals Incorporated- Balance Sheet
7.3 Vertex Pharmaceuticals Incorporated- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Vertex Pharmaceuticals Incorporated- Direct Competitors
8.2 Vertex Pharmaceuticals Incorporated- Competitor Financial Ratios comparison
8.3 Vertex Pharmaceuticals Incorporated- Competitor Stock Charts Comparison
8.4 Vertex Pharmaceuticals Incorporated- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$100- 50%
$100- 15%
$200- 10%
$100- 20%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!